EZElisa™小鼠乳腺癌抗雌激素抵抗蛋白3（Bcar3）E
LISA试剂盒-EZElisa™ Mouse Breast cancer anti-estrogen resistance protein 3 (Bcar3) ELISA Kit- 询价
- Biogradetech
- 美国
- A-QEK09712-96wells
- 2025年07月10日
企业认证
相关产品推荐更多 >
EZElisa™ SKI Like Oncogene（SKIL）试剂盒-EZElisa™ SKI Like Oncogene (SKIL) Kit
询价
EZElisa™人糖蛋白49A（Gp49a）ELISA试剂盒-EZElisa™ Human Glycoprotein 49A (Gp49a) ELISA Kit
询价
EZElisa™兴奋性氨基酸转运蛋白3（大鼠EAAT 3）ELISA试剂盒-EZElisa™ Excitatory Amino Acid Transporter 3 (Rat EAAT3) ELISA Kit
询价
EZElisa™人甲普林A β（MEP1b）ELISA试剂盒-EZElisa™ Human Meprin A Beta (MEP1b) ELISA Kit
询价EZElisa™溶血磷脂酰甘油酰基转移酶1（LPGAT 1）试剂盒-EZElisa™ Lysophosphatidylglycerol Acyltransferase 1 (LPGAT1) Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Mouse Breast cancer anti-estrogen resistance protein 3 (Bcar3) ELISA Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™小鼠乳腺癌抗雌激素抵抗蛋白3（Bcar3）ELISA试剂盒，EZElisa™ Mouse Breast cancer anti-estrogen resistance protein 3 (Bcar3) ELISA Kit，乳腺癌抗雌激素抵抗蛋白3（Bcar3）ELISA试剂盒, Mouse Breast cancer anti-estrogen resistance protein 3 (Bcar3) ELISA Kit
产品名称：EZElisa™小鼠凋亡调节因子BAX（Bax）ELISA试剂盒-EZElisa™ Mouse Breast cancer anti-estrogen resistance protein 3 (Bcar3) ELISA Kit
产品货号：A-QEK09712-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of Mouse Breast cancer anti-estrogen resistance protein 3 (Bcar3) ELISA in serum and plasma, tissue homogenates and other biological fluids.
种属：Mouse
检测方法：比色法
检测范围：78.125-5000pg/ml
该EZElisa™小鼠乳腺癌抗雌激素抵抗蛋白3（Bcar3）ELISA试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™小鼠凋亡调节因子BAX（Bax）ELISA试剂盒-EZElisa™ Mouse Breast cancer anti-estrogen resistance protein 3 (Bcar3) ELISA Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Anti-c-erb-B-2 Ribozyme for Breast Cancer
to aberrant growth, resulting in the malignant phenotype. Human breast cancer has been shown to exhibit c-erb -B-2 overexpression in 20–30% of examined tumors (9 ,10 ). The prognostic significance of c-erb -B-2 overexpression in breast cancer
Anti-c-erb1B2 Ribozyme for Gene Therapy of Breast Cancer
The application of antioncogene ribozyme in the gene therapy of breast cancer by means of recombinant adenoviral vector is dicussed in this chapter. We have shown that recombinant adenovirus encoding anti-cerbB2 ribozyme inhibited the breast
p53 Detection in Breast Cancer
of mutant p53 may itself be a prognostic factor in human breast cancer (5 ,6 ). Furthermore, a significant associatton between high levels of p53 and established pathologrcal crtteria (e.g, tumor stage, estrogen, and progesterone receptor levels
技术资料暂无技术资料 索取技术资料
